Document is current
Any future updates will be listed below
-
Authors
Shinagawa, Shunichiro
Onuki, Keisuke
Shimizu, Koichi
-
Funding
Funding for this research was provided by:
Otsuka Pharmaceutical Co., Ltd. (NA)
Otsuka Pharmaceutical Co., Ltd. (NA)
Otsuka Pharmaceutical Co., Ltd. (NA)
- License Information
-
More Information
Article History
Received: 16 March 2026
Accepted: 25 April 2026
First Online: 7 May 2026
Declarations
:
: Author S.S. has received speaking and lecture fees from Otsuka Pharmaceutical, Kowa, Sumitomo Pharma, Eisai, Takeda Pharmaceutical, MSD, Lundbeck, Eli Lilly Japan, and Viatris Pharmaceutical. He has also served advisory roles for Eisai, Otsuka Pharmaceutical, Eli Lilly Japan, and Ono Pharmaceutical. Authors K.O. and K.S. are employees of Otsuka Pharmaceutical Co., Ltd.
